South Korea
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
30.83%
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
2 |
8.12%
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
3 |
7.17%
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
4 |
5.81%
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
5 |
5.34%
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
6 |
1.98%
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
7 |
-0.38%
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
8 |
-1.67%
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
9 |
-3.69%
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
10 |
-3.94%
|
Dec. 31, 2023 | USD 9.61 | -3.70% |
|
South Korea |
|
11 |
-21.07%
|
Dec. 31, 2023 | USD 8.83 | 4.03% |
|
South Korea |
|
12 |
-106.48%
|
Dec. 31, 2023 | USD 10.77 | -3.15% |
|
South Korea |
|
13 |
-113.06%
|
Dec. 31, 2023 | USD 3.75 | -3.31% |
|
South Korea |
|
14 |
-193.16%
|
Dec. 31, 2023 | USD 1.42 | -2.25% |
|
South Korea |
|
15 |
-262.49%
|
Dec. 31, 2023 | USD 4.40 | -2.27% |
|
South Korea |
|
16 |
-512.27%
|
Dec. 31, 2023 | USD 1.65 | -4.10% |
|
South Korea |
|
17 |
-780.47%
|
Dec. 31, 2023 | USD 1.23 | -3.88% |
|
South Korea |
|
18 |
-1,048.48%
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
|
19 |
-1,129.99%
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
The Vaccines company in South Korea with the highest EBT Margin is Celltrion, Inc. (KSE: 068270.KS) at 30.83%.
The Vaccines company in South Korea with the lowest EBT Margin is Genexine, Inc. (KOSDAQ: 095700.KQ) at -1,129.99%.
The top 10 Vaccines companies in South Korea by EBT Margin are Celltrion, Inc., Daewoong pharmaceutical Co.,Ltd, Medy-Tox Inc., Dong-A Socio Holdings Co., Ltd., Samjin Pharmaceuticals Co., Ltd., SK bioscience Co.,Ltd., Seegene, Inc., Green Cross Corporation, ALTEOGEN Inc. and Green Cross Holdings Corporation.
The bottom 10 Vaccines companies in South Korea by EBT Margin are Genexine, Inc., CrystalGenomics, Inc., Gencurix Inc., SillaJen, Inc., Sugentech Inc., GeneOne Life Science, Inc., iNtRON Biotechnology, Inc., OliX Pharmaceuticals,Inc, EuBiologics Co., Ltd. and Green Cross Holdings Corporation.